Finance

Beta
Lists
182400:KOSDAQ
NKGen Biotech Korea Co ltd
₩2,020.00
-44.96%
(-1,650.00) 1D
Mar 25, 3:30:30 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 182400...
Mkt. cap
172.75B
Volume
0.00
P/E ratio
18.61
52-wk high
₩9,904
52-wk low
₩8,621
EPS
₩109
Shares outstanding
72.34M
No. of employees
72
Mkt. cap
172.75B
Volume
0.00
P/E ratio
18.61
52-wk high
₩9,904
52-wk low
₩8,621
EPS
₩109
Shares outstanding
72.34M
No. of employees
72
News stories
From sources across the web
About NKGen Biotech Korea Co ltd
CEO-
Employees72
Founded2002
Headquarters-
SectorBiotechnology
Websitenkmax.com
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
2.02B
2.21B
2.21B
1.57B
Cost of goods sold
407.13M
391.88M
578.36M
241.90M
Cost of revenue
407.13M
391.88M
578.36M
241.90M
Research and development expenses
456.26M
642.10M
454.60M
472.72M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.01B
1.23B
2.29B
1.65B
Operating expense
436.39M
1.86B
4.57B
2.54B
Total operating expenses
843.52M
2.25B
5.15B
2.78B
Operating income
1.18B
-48.73M
-2.93B
-1.21B
Other non operating income
215.88K
355.34M
-619.47M
7.56M
EBT including unusual items
2.47B
215.79M
-782.85M
-1.27B
EBT excluding unusual items
2.26B
509.09M
-3.68B
-1.30B
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
43.13M
43.89M
41.92M
58.49M
Net income
2.47B
215.79M
-782.85M
-1.27B
Net profit margin
122.19%
9.78%
-35.41%
-80.41%
Earnings per share
-
-
-
-
Interest and investment income
152.72M
162.88M
-
27.58M
Interest expense
-430.12M
-19.64M
-84.93M
-120.33M
Net interest expenses
-277.40M
143.24M
-84.93M
-92.75M
Depreciation and amortization charges
37.20M
42.78M
79.26M
200.33M
EBITDA
1.20B
8.66M
-2.84B
-990.92M
Gain or loss from assets sale
-
-106.27M
106.27M
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more